Glaucoma Is Silent Until It Is Not

Glaucoma is the condition eye care worries about most and patients worry about least, and the gap between those two positions is entirely explained by the absence of symptoms.

Why nobody notices

Glaucoma damages the optic nerve, and it does so from the outside in. Peripheral vision goes first, and it goes slowly.

The reason this is not noticed is that the brain does not present you with a black patch where vision is missing. It fills the gap using information from the surrounding area and from the other eye, in exactly the way it fills in your natural blind spot without you ever being aware of it.

So the experience of early and moderate glaucoma is simply normal vision. People routinely lose forty percent of the nerve fibres in an eye before noticing anything at all.

By the time vision loss is apparent, it is permanent.

The pressure misconception

Almost everybody knows glaucoma has something to do with eye pressure. That association is doing genuine harm, because it leads people to believe that a normal pressure reading means they are in the clear.

It does not. A substantial proportion of glaucoma occurs at pressures within the normal range, a form called normal tension glaucoma. In some populations it accounts for the majority of cases.

Raised pressure is a major risk factor and lowering pressure is the main treatment, so the association is not wrong. But pressure is one measurement among several, and treating it as a screening test on its own misses a great many people.

What proper screening looks at

Intraocular pressure

Still worth measuring, still a major risk factor, still the thing treatment targets. Just not sufficient alone.

The optic nerve head

The nerve head is directly visible and changes characteristically as fibres are lost. The cup at its centre enlarges, the rim of remaining tissue thins, and the pattern of that thinning is itself informative.

Documented imaging matters enormously here, because the appearance of a healthy optic nerve varies a great deal between individuals. What is suspicious is not any particular appearance but a change from that individual's own baseline.

Nerve fibre layer thickness on OCT

This is the measurement that has changed glaucoma detection most in the past two decades. OCT measures the thickness of the retinal nerve fibre layer in microns, and thinning is detectable before any visual field loss appears at all.

It means damage can be identified during the period when the patient has lost nothing they would ever notice, which is precisely when intervention is most valuable.

Visual field testing

This maps functional vision. Targets of varying brightness are presented across the field of view and you indicate which you can see. The result is a map of what the eye is genuinely detecting, including the areas the brain has been quietly filling in.

It is the test people find most tedious and it is not replaceable, because it measures function rather than structure.

Who is at raised risk

• Age, with risk rising substantially after fifty
• A first degree relative with glaucoma, which raises risk severalfold
• African or Hispanic ancestry, associated with earlier onset and faster progression
• Diabetes
• High myopia
• Previous significant eye injury
• Long term steroid use, including inhaled and topical steroids
• Thin corneas

Family history is the one most often unacted on, usually because nobody tells the relatives. If a parent or sibling has glaucoma, that is a specific reason to be screened regularly rather than a general one.

What treatment achieves

Treatment cannot restore vision that has been lost. What it does, reliably and effectively, is protect what remains.

Most glaucoma is managed with pressure lowering eye drops, used daily and indefinitely. Laser treatment is an option for many patients and surgical procedures exist for cases needing them. The great majority of people diagnosed with glaucoma retain useful vision for life, provided they are diagnosed and remain in monitoring.

The determining variable in outcome is not which treatment is used. It is how early the condition was found.

How often to be screened

Screening forms part of every comprehensive eye examination here, which for most adults means annually.

Anyone with risk factors, suspicious optic nerve appearance, borderline pressures or thin nerve fibre measurements is monitored more frequently, typically every six to twelve months, because in those cases the question is not whether there is damage today but whether there is change over time.

That is the whole discipline of glaucoma care: establishing a baseline, then watching for movement away from it.

What treatment actually involves

A glaucoma diagnosis sounds more dramatic than the daily reality of managing it, which for most people is a drop at bedtime.

• Eye drops. The mainstay. Usually once daily, usually for life. They work by reducing the fluid the eye produces or improving how it drains. Adherence is the single biggest determinant of outcome, and it is also the thing people are worst at.
• Laser treatment. A short outpatient procedure that improves drainage. Increasingly used earlier rather than as a fallback, and it can reduce or remove the need for drops for a period.
• Surgery. For cases not controlled by the above. Effective, and reserved for where it is needed.

The practical difficulty with drops is not the drops. It is that the condition produces no symptoms, so there is no feedback telling you that missing a week mattered. It did.

The visual field test, explained

This is the test patients find most tedious and most confusing, and understanding what it is doing makes it noticeably easier to sit through.

You look at a central target and press a button whenever you notice a light appear anywhere in your peripheral vision. The lights vary in brightness. The machine is not testing whether you can see, it is finding the dimmest light you can detect at each of many specific locations, and building a sensitivity map from that.

Two things follow from this. First, you are supposed to miss some. If you saw every light the test would have told us nothing about your threshold. Second, guessing is unhelpful and so is pressing constantly, because both distort the map. Press when you notice something, and accept that you will be unsure sometimes.

The test also measures your reliability, using repeat presentations and points in your natural blind spot. A field with poor reliability indices gets repeated rather than interpreted.

Living with a diagnosis

The honest position is that most people diagnosed with glaucoma and kept in monitoring retain useful vision for life. It is a condition managed over decades rather than an event.

• Take the drops. Every day, at the same time. Set an alarm if needed. This is genuinely the whole game.
• Keep the appointments. Detection of change is what treatment decisions are based on, and change is only visible against your own previous measurements.
• Tell relatives. A first degree relative has a severalfold raised risk and mostly does not know it.
• Mention every medication. Steroids in any form can raise eye pressure.
• Ask about your driving field if you drive. It is measurable and it is better to know.

What is not required is giving things up. Exercise, reading, screen work and normal life are unaffected by glaucoma in its managed form.

Getting the drops in, which is harder than it sounds

Adherence is the single largest determinant of outcome in glaucoma, and a substantial share of poor adherence is not forgetfulness but technique.

• Tilt your head back, pull the lower lid down to make a pocket, and look up. Aim for the pocket, not the eye itself.
• One drop is the dose. The pocket holds less than a drop, so a second is wasted and increases any side effect.
• After the drop, close the eye gently and press the inner corner near the nose for about a minute. This stops the drop draining into the nose, which both wastes it and is where most systemic side effects come from.
• Wait five minutes between different drops, or the second washes out the first.
• If you wear contact lenses, check whether the drop requires removing them. Many preserved drops do.

If the bottle is difficult to squeeze, or you cannot tell whether a drop went in, say so. Compliance aids exist and the problem is common enough that nobody is surprised by it.